FMS-Like Tyrosine Kinase 3 (FLT3)-Mutated Acute Myeloid Leukemia
1 clinical trials · Condition
◉ Watch FMS-Like Tyrosine Kinase 3 (FLT3)-Mutated Acute Myeloid Leukemia
| Record | Firm | Date |
|---|---|---|
| Managed Access Programs for PKC412, Midostaurin (NCT05219266) | Novartis Pharmaceuticals |
Track FMS-Like Tyrosine Kinase 3 (FLT3)-Mutated Acute Myeloid Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.